health-technologyNVIDIA BioNeMo Platform Secures Partnerships with Eli Lilly, Thermo Fisher for AI Drug DiscoverySalvado•Apr 21, 2026
BiotechGlobal Biotech Valuations Rise as $120B Oncology Pipeline Targets 2026-2027 FDA ApprovalsSalvado•Apr 18, 2026
AI & TechnologyNVIDIA Locks Down Global Pharma AI Infrastructure Through Eli Lilly, Thermo Fisher Platform DealsSalvado•Apr 11, 2026
BusinessNVIDIA Secures Thermo Fisher, Eli Lilly Partnerships for BioNeMo Drug Discovery PlatformSalvado•Apr 10, 2026
health-techNVIDIA's Drug Discovery AI Platform Secures Eli Lilly, Thermo Fisher Partnerships Across Three ContinentsSalvado•Mar 29, 2026
biotechnologyWave Life Sciences Obesity Trial Shows Baseline BMI Gaps Skew Efficacy Data Across Global Drug RaceSalvado•Mar 28, 2026
Healthcare & PharmaceuticalsU.S. Rare Disease Drugmaker Faces $200M Revenue Loss as Patent Cliff Looms in 2035ViaNews Editorial Team•Mar 12, 2026
pharmaceuticalsBiotech Kyntra Bio Risks 60-80% Wipeout as Single Cancer Drug FG-3246 Faces Trial VerdictViaNews Editorial Team•Feb 26, 2026
Healthcare & PharmaceuticalsGlobal Pharma Giants Redraw Strategic Maps as M&A Wave and Pipeline Milestones Reshape the SectorViaNews Editorial Team•Feb 18, 2026
AnalysisMajor Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA ApprovalsViaNews Editorial Team•Feb 15, 2026
